A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clini...
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clini...
Carers from the Formació i Treball APROP job pool provide home care for people in the early stages of a bone marrow transplant. Between 2020 and 2...
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood ca...
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug...
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with...
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and...
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘imm...
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS o...
Patients with multiple myeloma and mobility problems who receive treatment at home improve their quality of life by avoiding repeated visits to the...
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining...